The Medical University of South Carolina (MUSC) has launched two venture capital funds totaling $30 million to support healthcare innovation and entrepreneurship in South Carolina.
Why it matters: The funds aim to bridge the gap between academic research and commercial viability, stimulating economic development and attracting private investment to the state.
The details:
- The $20 million 1824 Health Ventures Fund I, LP will provide seed capital for MUSC-originated startups and emerging companies transforming healthcare.
- The $10 million South Carolina Health Innovation Fund (SCHIF), LLC, a partnership between MUSC Health and the state’s Small Business Credit Initiative (SSBCI) administrator, will support high-impact health innovation companies both within and outside MUSC.
- Both funds will be managed by Bob Crutchfield, a senior executive with over 30 years of leadership experience in international companies, startups, and venture capital firms.
- The funds are expected to support the creation and expansion of businesses and high-wage STEM jobs in South Carolina.
South Carolina, currently ranked 45th in the nation in venture capital activity, experienced the 10th highest growth rate in venture capital relative to GDP from 2012 to 2022, highlighting its untapped potential.
What they’re saying:
- “These funds represent a transformational step in turning South Carolina into a national destination for health innovation and entrepreneurship,” said David J. Cole, M.D., FACS, President of MUSC.
- “By building an evergreen investment model, we’re laying the foundation for a durable and consequential innovation ecosystem across South Carolina,” said Will Cruz, chief investment officer of InvestSC.
“It takes a lot of money to go from scientific opportunity to validation, to building out and getting through your clinical trial progressions in order to have a commercial chance,” said Bob Crutchfield, fund manager.
The impact: The funds are expected to stimulate South Carolina’s economy through innovation, supporting the creation of businesses and high-wage STEM jobs in the state.
What’s next: MUSC aims to attract further private investment and create a ripple effect that will boost the South Carolina medical industry, leading to commercial successes benefiting patients nationwide.